NCT04333654 - Hydroxychloroquine in Outpatient Adults With COVID-19 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 12, 2020

Primary Completion Date

May 26, 2020

Study Completion Date

May 26, 2020

Conditions

Coronavirus Infection

Interventions

DRUG

Hydroxychloroquine SAR321068

Pharmaceutical form:Tablet Route of administration: Oral

DRUG

Placebo

Pharmaceutical form:Tablet Route of administration: Oral

Trial Locations (7)

Investigational Site Number 0561002, Lodelinsart

Investigational Site Number 2501001, Bordeaux

Investigational Site Number 2501002, Paris

Investigational Site Number 8400001, Boston

Investigational Site Number 0561001, Brussels

Investigational Site Number 5281001, Groningen

Investigational Site Number 5281002, Harderwijk